Research for Prevention and Treatment of NSAIDs Related Gastrointestinal Side Effects
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
We aim to evaluate the protective effects of eradication of HP and continue using
Geranylgeranylacetone (GGA) on NSAIDs related gastroenterological lesions. We further aim to
explore the effect of GGA on small-intestinal mucosal injuries induced by diclofenac sodium
in patients with rheumatic diseases who didn't take NSAIDs in the preceding 6 months.